Prokarium
Latest round
- Series B
Last raised
- Oct 2020
Total raised
- $39M
Investors
- 4
About Prokarium
Founded in 2012 and headquartered in London, UK, Prokarium Ltd. specializes in biopharmaceuticals, focusing on microbial immunotherapies.Prokarium is a biopharmaceutical company specializing in innovative cancer treatments, focusing primarily on microbial immunotherapy. Its core product offerings include a proprietary strain of Salmonella, ZH9, utilized as a microbial immunotherapy platform to treat bladder cancer. The lead program is designed to transform the treatment paradigm for non-muscle invasive bladder cancer cases. Prokarium leverages synthetic biology to create an oral immune training agent aimed at restoring anti-tumor responses and enhancing the effectiveness of current immunotherapies.80 for 2023. The company’s revenue model is based on partnerships and collaborations with healthcare providers and research institutions to advance its clinical programs, focusing on successful clinical milestones and potential commercialization of its therapies.Prokarium's growth strategy includes advancing its clinical programs and expanding its product offerings through research and development. The company is targeting further penetration into North American and European markets, with plans to enhance its portfolio of innovative cancer treatments aimed at improving patient outcomes.
Who invested in Prokarium
4 investors across 3 rounds
See all investors in Prokarium
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prokarium
Who invested in Prokarium?
Prokarium has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prokarium raised?
Prokarium has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Prokarium last raise money?
Prokarium's most recent round on record is a Series B, in Oct 2020.
What does Prokarium do?
Founded in 2012 and headquartered in London, UK, Prokarium Ltd.
Where is Prokarium headquartered?
Prokarium is headquartered in London, UK.
Which VCs invest in companies like Prokarium?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Prokarium's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Prokarium? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.